Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.

Hemmaway CJ, Danga A, Igbokwe U, Radunovic A.

Br J Haematol. 2012 Sep;158(6):678. doi: 10.1111/j.1365-2141.2012.09237.x. Epub 2012 Jul 24. No abstract available.

PMID:
22823157
2.

18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.

Odawara J, Asada N, Aoki T, Yamakura M, Takeuchi M, Ohuchi T, Matsue K.

Br J Haematol. 2007 Mar;136(5):684. Epub 2006 Nov 27. No abstract available.

PMID:
17129231
3.

Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.

Takeoka Y, Inaba A, Fujitani Y, Kosaka S, Yamamura R, Senzaki H, Okamura T, Ohta K.

Rinsho Ketsueki. 2011 Nov;52(11):1777-81.

PMID:
22185801
4.

Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.

Wagner T, Brechemier D, Dugert E, Le Guellec S, Julian A, Hitzel A, Beyne-Rauzy O.

Cancer Imaging. 2012 Jan 23;12:7-12. doi: 10.1102/1470-7330.2012.0002.

5.

Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.

Hoshino A, Kawada E, Ukita T, Itoh K, Sakamoto H, Fujita K, Mantani N, Kogure T, Tamura J.

Am J Hematol. 2004 Jul;76(3):236-9.

6.

FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.

Colavolpe C, Ebbo M, Trousse D, Khibri H, Franques J, Chetaille B, Coso D, Ouvrier MJ, Gastaud L, Guedj E, Schleinitz N.

Hematol Oncol. 2015 Jun;33(2):99-109. doi: 10.1002/hon.2140. Epub 2014 May 21. Review.

PMID:
24850057
7.

A neurological presentation of intravascular B-cell lymphoma.

Kendall KM, Thomas RH, Corkill RG, Robertson NP.

BMJ Case Rep. 2012 Aug 2;2012. pii: bcr2012006439. doi: 10.1136/bcr-2012-006439.

8.

Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.

Wu X, Pertovaara H, Korkola P, Vornanen M, Järvenpää R, Dastidar P, Eskola H, Kellokumpu-Lehtinen PL.

Acta Oncol. 2014 Aug;53(8):1093-9. doi: 10.3109/0284186X.2014.927074. Epub 2014 Jun 24.

PMID:
24960581
9.

Disseminated diffuse large B cell lymphoma of bone on PET scan.

Chen WL, Ho CL.

Int J Hematol. 2008 Jul;88(1):1-2. doi: 10.1007/s12185-008-0097-0. Epub 2008 May 15. No abstract available.

PMID:
18478313
10.

Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.

Hosokai R, Imai C, Takachi T, Yoshida S, Iwabuchi H, Imamura M, Uchiyama M.

J Pediatr Hematol Oncol. 2011 Mar;33(2):e87-8. doi: 10.1097/MPH.0b013e3181f69205.

PMID:
21317812
11.

[Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].

Yago K, Yanagita S, Aono M, Matsuo K, Shimada H.

Rinsho Ketsueki. 2009 Jun;50(6):499-502. Japanese.

PMID:
19571511
12.

Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.

Miyazaki Y, Nawa Y, Miyagawa M, Kohashi S, Nakase K, Yasukawa M, Hara M.

Ann Hematol. 2013 Jan;92(2):239-44. doi: 10.1007/s00277-012-1602-3. Epub 2012 Oct 19.

13.

Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation.

Dabaja BS, Hess K, Shihadeh F, Podoloff DA, Medeiros LJ, Mawlawi O, Arzu I, Oki Y, Hagemeister FB, Fayad LE, Reed VK, Kedir A, Wogan CF, Rodriguez A.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):384-91. doi: 10.1016/j.ijrobp.2014.02.015. Epub 2014 Apr 7.

PMID:
24721592
14.

[Intravascular large B-cell lymphoma with massive pulmonary lesions].

Higashiyama A, Hashino S, Onozawa M, Takahata M, Okada K, Kahata K, Taniguchi N, Nasuhara Y, Kubota K, Fujimoto N, Matsuno Y, Nishimura M, Asaka M.

Rinsho Ketsueki. 2010 May;51(5):353-6. Review. Japanese.

PMID:
20534958
15.

[Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].

Masada T, Matsumoto Y, Kawai N, Tamiya T, Nagao S.

No Shinkei Geka. 2004 Aug;32(8):859-64. Japanese.

PMID:
15478653
16.

[Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].

Banzo J, Ubieto MA, Giraldo P, Razola P, Prats E, Tardin L, Santapau A, Parra A, Rambalde EF, Velilla J.

Rev Esp Med Nucl Imagen Mol. 2012 Mar-Apr;31(2):89-92. doi: 10.1016/j.remn.2011.03.018. Epub 2011 May 26. Spanish.

17.

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJ, Vitolo U, Stelitano C, Brusamolino E, Cabras MG, Rigacci L, Balzarotti M, Salvi F, Montoto S, Lopez-Guillermo A, Finolezzi E, Pileri SA, Davies A, Cavalli F, Giovanella L, Johnson PW.

J Clin Oncol. 2014 Jun 10;32(17):1769-75. doi: 10.1200/JCO.2013.51.7524. Epub 2014 May 5.

PMID:
24799481
18.

Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.

Pardal E, Coronado M, Martín A, Grande C, Marín-Niebla A, Panizo C, Bello JL, Conde E, Hernández MT, Arranz R, Bargay J, González-Barca E, Pérez-Ceballos E, Montes-Moreno S, Caballero MD.

Br J Haematol. 2014 Nov;167(3):327-36. doi: 10.1111/bjh.13036. Epub 2014 Jul 28.

PMID:
25066542
19.

Early diagnosis of hepatic intravascular lymphoma: a case report and literature review.

Abe H, Kamimura K, Mamizu M, Shibazaki Y, Ishiguro T, Katada S, Nishiyama YK, Takahashi Y, Hatano YY, Mizuno K, Watanabe Y, Nagashima A, Takizawa J, Takeuchi M, Kawai H, Nomoto M, Sone H, Nishizawa M, Aoyagi Y.

Intern Med. 2014;53(6):587-93. Review.

20.

Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.

Cox MC, Ambrogi V, Lanni V, Cavalieri E, Pelliccia S, Scopinaro F, Monarca B, Marchetti P, Spiriti MA.

Leuk Lymphoma. 2012 Feb;53(2):263-9. doi: 10.3109/10428194.2011.614704. Epub 2011 Sep 23.

PMID:
21846184

Supplemental Content

Support Center